Related Experiment Video
Updated: Jan 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma-Beyond Albuterol
Christopher S Amato1, Mahsa Akhavan-Pajoohi1
1Departments of Emergency Medicine & Pediatrics, Sydney Kimmel Medical College at Jefferson University, Philadelphia, USA.
Insights
Pediatric asthma remains a significant health concern. This review identifies evidence-based treatments to improve outcomes for children with asthma.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Pediatrics
Background:
- Asthma is a prevalent chronic respiratory condition in children.
- Despite advances in care, pediatric asthma significantly contributes to morbidity and mortality.
- Effective management strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To review evidence-based literature on pediatric asthma treatments.
- To identify therapeutic interventions that optimize patient response.
- To provide guidance for managing childhood asthma.
Main Methods:
- Systematic review of evidence-based literature.
- Analysis of treatment efficacy in pediatric asthma patients.
- Synthesis of current research on asthma management.
Main Results:
- Identification of key evidence-based treatment options for pediatric asthma.
- Evaluation of treatment effectiveness based on scientific literature.
- Summary of best practices for managing childhood respiratory disorders.
Conclusions:
- Optimized treatment selection is vital for improving pediatric asthma outcomes.
- Evidence-based interventions can mitigate asthma's impact on children.
- Continued research and application of findings are essential for advancing pediatric respiratory care.
Abstract:
Asthma is the most common respiratory disorder in children with a continued significant morbidity and mortality rate despite advancements made in the care of these patients. This review looks at the evidence-based literature to provide those treatments which will provide the best possible response from these patients.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Asthma-I: Introduction

